Tandem Diabetes Care Inc (TNDM) financials
Tandem Diabetes Care revenue and earnings by year
Tandem Diabetes Care's revenue was $1.01 billion in the fiscal year to December 31, 2025, up 7.9% from the year before. Net income was -$205 million, -20.2% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 31.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.01 | 0.94 | 0.75 | 0.80 | 0.70 | 0.50 | 0.36 | 0.18 | 0.11 | 0.08 |
| Revenue growth | 7.9% | 25.7% | -6.7% | 14.0% | 40.9% | 37.7% | 97.0% | 70.9% | 27.7% | — |
| Gross profit | 0.55 | 0.49 | 0.37 | 0.41 | 0.38 | 0.26 | 0.19 | 0.09 | 0.04 | 0.02 |
| Gross margin | 53.8% | 52.1% | 49.2% | 51.5% | 53.5% | 52.2% | 53.6% | 48.9% | 41.0% | 28.0% |
| Operating income | -0.19 | -0.10 | -0.23 | -0.09 | 0.02 | -0.01 | -0.02 | -0.04 | -0.06 | -0.08 |
| Operating margin | -18.5% | -10.5% | -31.2% | -11.6% | 3.2% | -1.6% | -4.6% | -24.3% | -58.5% | -92.6% |
| Net income | -0.20 | -0.10 | -0.22 | -0.09 | 0.02 | -0.03 | -0.02 | -0.12 | -0.07 | -0.08 |
| Net margin | -20.2% | -10.2% | -29.8% | -11.8% | 2.2% | -6.9% | -6.8% | -66.7% | -67.9% | -99.0% |
| Diluted EPS | -$3.07 | -$1.46 | -$3.44 | -$1.48 | $0.23 | -$0.63 | -$0.48 | — | — | -$27.31 |
| Free cash flow | -0.03 | 0.00 | -0.06 | 0.02 | 0.10 | -0.00 | 0.02 | -0.01 | -0.07 | -0.07 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open TNDM in Markets.
How Tandem Diabetes Care makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Supplies & Other | $140M | 55.0% |
| Pump | $115M | 45.0% |
See also: TNDM returns
No forecast, no recommendation. This page describes Tandem Diabetes Care Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.